25 Leading Radiotherapy Companies Shaping the Market Landscape Through 2030
Discover the top 25 companies revolutionizing cancer treatment through advanced radiotherapy technologies. This in-depth analysis explores competitive advantages, cutting-edge innovations, and key players poised to transform global oncology care and radiation therapy delivery through 2030. Access the comprehensive market research report here for further insights.
Spotlights on the Industry's Top Radiotherapy Companies
The global radiotherapy market, valued at US$6.23 billion in 2022 and US$7.21 billion in 2024, is projected to reach US$9.62 billion by 2030 at a CAGR of 4.9%. This growth is driven by advances in radiation treatment technology, rising cancer incidence, patient population expansion, and increased radiotherapy awareness initiatives. The strategic adoption of particle therapy, precision imaging guidance, and AI-integrated treatment planning systems positions these 25 industry leaders at the forefront of cancer care transformation.
1. Siemens Healthineers AG (Varian Medical Systems, Inc.)
Siemens Healthineers, through its acquisition of Varian Medical Systems, commands a dominant position in radiotherapy solutions. Their comprehensive portfolio spans external beam radiation therapy (EBRT), imaging-guided radiotherapy (IGRT), and advanced treatment planning systems. Varian's TrueBeam and Halcyon platforms deliver precision cancer treatment with enhanced workflow efficiency. Their integration of AI and machine learning optimizes treatment planning and patient outcomes globally.
2. Elekta
Elekta stands as a pioneering force in radiotherapy and radiosurgery innovation. Their Versa HD and CyberKnife systems deliver stereotactic radiosurgery (SRS) and stereotactic body radiation therapy (SBRT) with unparalleled precision. Elekta's commitment to advancing treatment modalities for prostate, breast, lung, and colorectal cancers drives market leadership. Their software solutions integrate image guidance, intensity-modulated radiation therapy (IMRT), and personalized medicine approaches.
3. Accuray Incorporated
Accuray specializes in robotic-guided radiotherapy systems, renowned for delivering highly conformal radiation treatment. Their CyberKnife M6 and TomoTherapy platforms provide rapid, non-invasive cancer treatment with exceptional targeting accuracy. Accuray's advanced motion management and real-time imaging capabilities enable effective treatment of complex tumors. Their focus on adaptive radiotherapy supports improved clinical outcomes across multiple cancer types.
4. IBA Worldwide
IBA Worldwide leads the particle therapy revolution, delivering proton and carbon ion therapy systems for precision cancer treatment. Their ProteusONE and ProteusPlus platforms enable advanced tumor targeting with reduced healthy tissue exposure. IBA's expertise in particle acceleration, treatment planning, and imaging guidance positions them as innovation catalysts in next-generation radiotherapy. Their commitment to making particle therapy accessible globally drives market expansion.
5. ViewRay, Inc.
ViewRay revolutionizes radiotherapy through MRI-guided radiation therapy (MRgRT) technology. Their MRIdian system integrates real-time MRI imaging with radiation delivery, enabling visualization of soft tissue targets during treatment. This innovative approach enhances precision for prostate, breast, and abdominal cancers while reducing imaging radiation dose. ViewRay's technology advances adaptive radiotherapy and personalized cancer treatment paradigms.
6. Perspective Therapeutics
Perspective Therapeutics specializes in compact, cost-effective radiotherapy solutions designed for global healthcare accessibility. Their systems bring advanced radiation treatment capabilities to resource-limited settings and emerging markets. Perspective's commitment to democratizing radiotherapy technology expands cancer care access for underserved populations worldwide.
7. Hitachi Ltd. (Hitachi High-Tech Corporation)
Hitachi leverages advanced engineering expertise to deliver comprehensive radiotherapy solutions. Their proton therapy systems and superconducting magnet technology enhance radiation delivery precision and safety. Hitachi's integration of digital imaging and treatment planning systems supports optimized cancer therapy protocols. Their commitment to technological excellence drives adoption across major medical centers globally.
8. Sumitomo Heavy Industries, Ltd.
Sumitomo Heavy Industries pioneers proton and particle therapy accelerator technology. Their compact, cost-effective accelerator designs expand particle therapy accessibility globally. Sumitomo's expertise in precision engineering and radiation physics enables advanced cancer treatment systems. Their commitment to innovation positions them as key enablers of next-generation radiotherapy infrastructure.
9. Carl Zeiss Meditec AG
Carl Zeiss Meditec advances radiotherapy through advanced imaging and surgical visualization technologies. Their integration of precision optics with radiotherapy planning and guidance systems enhances treatment accuracy. Carl Zeiss's commitment to optical excellence and surgical innovation supports superior oncology outcomes across cancer treatment modalities.
10. MIM Software Inc.
MIM Software leads in medical imaging and radiation oncology software solutions. Their advanced algorithms enable sophisticated image registration, fusion, and radiotherapy treatment planning. MIM's platforms support intensity-modulated radiation therapy (IMRT), stereotactic procedures, and adaptive therapy workflows. Their software innovation drives precision medicine and improved patient outcomes.
11. Panacea Medical Technologies Pvt. Ltd.
Panacea Medical Technologies develops affordable, high-quality radiotherapy solutions for emerging markets. Their linear accelerators and treatment planning systems meet international standards while maintaining cost-effectiveness. Panacea's mission to expand cancer care access drives innovation in budget-conscious healthcare settings globally.
12. Provision Healthcare
Provision Healthcare specializes in proton therapy delivery and treatment planning solutions. Their compact proton systems and advanced dose optimization algorithms enable precise tumor targeting while minimizing normal tissue exposure. Provision's commitment to proton therapy accessibility supports expansion of particle-based cancer treatment globally.
13. Mevion Medical Systems
Mevion Medical Systems pioneers compact superconducting proton therapy systems. Their innovative accelerator design and treatment planning technology advance precision particle therapy. Mevion's commitment to making proton therapy economically viable and geographically accessible drives market transformation and cancer care improvement.
14. Koninklijke Philips N.V.
Philips advances radiotherapy through comprehensive imaging, monitoring, and guidance solutions. Their diagnostic imaging systems, ultrasound, and adaptive monitoring technologies enhance treatment precision and workflow efficiency. Philips' integrated healthcare solutions support personalized cancer treatment protocols and improved clinical outcomes.
15. Shinva Medical Instrument Co., Ltd.
Shinva Medical Instrument manufactures quality radiotherapy equipment and systems. Their linear accelerators and treatment planning solutions support effective cancer care delivery. Shinva's commitment to engineering excellence and regulatory compliance strengthens their market presence in Asia-Pacific and emerging regions.
16. Brainlab AG
Brainlab specializes in advanced radiotherapy planning and guidance software solutions. Their sophisticated algorithms enable precise targeting, adaptive therapy, and real-time treatment monitoring. Brainlab's integration of artificial intelligence and machine learning optimizes radiation dose distribution and treatment outcomes across cancer types.
17. RaySearch Laboratories
RaySearch Laboratories leads in radiotherapy software development and treatment optimization algorithms. Their advanced planning systems enable intensity-modulated radiation therapy (IMRT), adaptive therapy, and personalized dose calculations. RaySearch's innovation in radiotherapy informatics drives precision oncology and improved patient care globally.
18. Optivus Proton Therapy, Inc.
Optivus Proton Therapy develops innovative proton beam delivery systems and treatment planning technologies. Their patient-specific aperture and range modulation approaches enhance proton therapy precision. Optivus's commitment to making proton therapy accessible supports expansion of particle-based cancer treatment.
19. Bebig Medical
Bebig Medical specializes in brachytherapy solutions, delivering internal radiation therapy for gynecological, prostate, and other cancers. Their innovative applicators, source delivery systems, and treatment planning software enable precise high-dose-rate (HDR) and low-dose-rate (LDR) brachytherapy. Bebig's expertise in targeted radiation delivery supports superior clinical outcomes.
20. P-Cure
P-Cure develops compact, innovative proton therapy systems designed for accessibility and cost-effectiveness. Their advanced accelerator technology and treatment delivery systems advance global proton therapy adoption. P-Cure's mission to democratize particle therapy expands cancer treatment options worldwide.
21. Theragenics Corporation
Theragenics specializes in radioactive seed brachytherapy solutions for prostate cancer and other malignancies. Their precision seed placement and treatment planning systems enable effective internal radiation therapy. Theragenics' expertise in brachytherapy advances minimally invasive cancer treatment options.
22. ProTom International
ProTom International pioneers hybrid proton and photon therapy systems combining external beam radiation with particle therapy capabilities. Their integrated approach enables optimized treatment planning for complex tumors. ProTom's innovation in combined modality radiotherapy advances precision oncology.
23. DOSIsoft SA
DOSIsoft specializes in advanced dose calculation and treatment planning software for radiotherapy. Their sophisticated algorithms enable accurate dose prediction and optimization for external beam and brachytherapy. DOSIsoft's software solutions drive precision medicine and improved therapeutic outcomes.
24. IsoAid, LLC
IsoAid specializes in brachytherapy source manufacturing and delivery systems. Their radioactive source production and applicator design enable safe, effective internal radiation therapy. IsoAid's commitment to brachytherapy advancement supports improved outcomes for gynecological, prostate, and other cancers.
25. MagnetTx Oncology Solutions Ltd.
MagnetTx Oncology Solutions develops innovative magnetic resonance imaging integrated radiotherapy systems. Their MR-linac technology combines real-time soft tissue imaging with radiation delivery for enhanced treatment precision. MagnetTx's commitment to MRI-guided radiotherapy advances adaptive, personalized cancer treatment.
80% of the Forbes Global 2000 B2B companies rely on MarketsandMarkets to identify growth opportunities in emerging technologies and use cases that will have a positive revenue impact.
- Food Packaging Market Size Set for Strong Growth Through 2030 Amid Rising Demand for Convenience Foods
- Crop Protection Chemical Market Size, Share & Growth Forecast (2025–2030)
- Mulch Films Market: Driving Sustainable Agriculture Through Innovation
- Agricultural Adjuvants Market Analysis, Trends, and Growth Outlook (2026–2031)
- Leading Automated Guided Vehicle Companies 2024: An In-depth Analysis
Conclusion: Unlock the Full Radiotherapy Market Intelligence
The global radiotherapy market's evolution through 2030 is shaped by technological innovation, treatment personalization, and strategic adaptation among industry leaders. Advances in imaging-guided radiotherapy (IGRT), intensity-modulated radiation therapy (IMRT), stereotactic procedures, particle therapy, and AI-integrated treatment planning drive market transformation. To explore comprehensive trends, segmentation insights, and actionable recommendations for sustainable growth, access the full detailed report covering Radiotherapy Market by Technology (EBRT: MR LINAC, Stereotactic, Particle; IBRT/Brachytherapy, Cobalt-60 Teletherapy), Procedure (IGRT, IMRT, 3D-CRT, HDR, LDR, PDR), Cancer Type (Prostate, Breast, Lung, Colorectal), End User (Hospital, Imaging Research Center) - Global Forecasts to 2030.

